Teva to Host Conference Call to Discuss Second Quarter 2026 Financial Results on July 29, 2026 at 8 a.m. ET Notified -
Mùa bóng đá 2026 khởi tranh – LEPAS đồng hành cùng bạn theo đuổi đam mê với phong thái điềm tĩnh Notified -
Teva Submits NDA for Ecopipam, a First-in-Class Investigational Therapy for Pediatric Tourette Syndrome Notified -
WeRide, Geely Farizon and Kwoon Chung Launch Right-Hand-Drive Robotaxis at the 2026 International Automotive & Supply Chain Expo (Hong Kong), Accelerating Global Expansion Notified -
Boehringer Ingelheim accelerates precision oncology research with initiation of three Phase III trials in hard-to-treat cancers Notified -
Professor Mohamed Shamji Assumes Presidency of EAACI as Congress 2026 Concludes in Istanbul Notified -
Valeura Energy Inc.: Completion of Nong Yao Drilling Campaign Including First Multi-Lateral Notified -
Teva Submits NDA for Ecopipam, a First-in-Class Investigational Therapy for Pediatric Tourette Syndrome Notified -